Fairtility Expands European Market Penetration with CHLOE EQ ™, as Clinics in Five Countries Embrace Breakthrough AI Technology in IVF
“We selected CHLOE EQ because of its ability to provide quantifiable biological data on embryo development, quality and viability. This transparency and interpretability set it apart from other AI-based decision support tools available,” said Shabana Sayed, Senior Embryologist and IVF Lab Manager at Klinikk Hausken, part of Medicover. “Our embryologists see this system as a companion that helps augment and standardize decision making. It speaks to them in a language they understand –human biology.”
June 7, 2023
